Chronic glomerulonephritis is a progressive kidney condition that develops slowly over months or years, causing inflammation in the tiny filtering units of the kidneys and potentially leading to serious complications if not properly managed.

Understanding Your Options When Facing Chronic Kidney Inflammation

When someone receives a diagnosis of chronic glomerulonephritis, it marks the beginning of a journey that requires careful attention to treatment and lifestyle adjustments. The main goals of treatment focus on slowing down the progression of kidney damage, managing symptoms such as swelling and high blood pressure, and preventing the condition from advancing to kidney failure. Treatment approaches vary significantly depending on what caused the inflammation in the first place, how severe the damage has become, and the individual characteristics of each patient.^[1]

Medical societies have developed standard treatment guidelines that doctors follow, but there is also ongoing research exploring new therapies through clinical trials. These studies test experimental medications and innovative approaches that may become tomorrow’s standard treatments. The treatment landscape continues to evolve as researchers better understand the mechanisms that drive chronic glomerular damage and identify new targets for intervention.^[2]

Nearly all forms of acute glomerulonephritis have a tendency to progress toward chronic disease if not addressed early. The chronic form is characterized by irreversible and progressive glomerular and tubulointerstitial fibrosis (scarring of kidney tissue), which ultimately leads to a reduction in the glomerular filtration rate, or GFR (a measure of how well kidneys filter blood), and retention of uremic toxins. Chronic glomerulonephritis is the third leading cause of chronic kidney disease and accounts for about 10% of all patients on dialysis for end-stage kidney disease.^[2]

Standard Medical Treatment for Chronic Glomerulonephritis

The foundation of treating chronic glomerulonephritis involves addressing the underlying cause while managing complications. Treatment recommendations from the Kidney Disease: Improving Global Outcomes guidelines focus on several key areas that work together to protect kidney function and improve quality of life.^[9]

Blood Pressure Control and Kidney Protection

Controlling high blood pressure is one of the most important aspects of treatment because hypertension can cause further kidney damage and create a harmful cycle. Doctors commonly prescribe medications called angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin receptor blockers (ARBs). These medications work by relaxing blood vessels and reducing pressure within the tiny filtering units of the kidneys. They also help decrease the amount of protein that leaks into the urine, which is a sign of kidney damage.^[8]

Examples of ACE inhibitors include enalapril, captopril, lisinopril, benazepril, and fosinopril. These medications prevent the conversion of angiotensin I to angiotensin II, a powerful substance that constricts blood vessels. This results in lower aldosterone secretion and decreased pressure inside the glomeruli. Many patients with high blood pressure and kidney disease need to take several medicines together to adequately control their blood pressure.^[15]

ARBs work similarly to ACE inhibitors but through a slightly different mechanism. They are often used when patients cannot tolerate ACE inhibitors. Both types of medication are commonly prescribed even if blood pressure is not particularly high because they help protect kidney function.^[8]

Managing Fluid Retention and Swelling

When kidneys are damaged, they cannot remove excess fluid from the body effectively. This leads to swelling in the face, hands, feet, and legs. Doctors prescribe diuretics (water pills) to help the body eliminate extra fluid. Loop diuretics are commonly used because they work on a specific part of the kidney to increase urine production. Patients are also advised to restrict their dietary sodium intake, which helps control fluid accumulation.^[9]

Immunosuppressive Therapy

If chronic glomerulonephritis is caused by problems with the immune system attacking the kidneys, doctors may recommend medicines called immunosuppressants. These drugs suppress the immune system to prevent it from continuing to damage kidney tissue. The most commonly used immunosuppressant for glomerulonephritis is prednisolone, a steroid medication that reduces swelling and inflammation.^[8]

Treatment with steroids typically begins with higher doses, which are gradually reduced as the kidneys start to recover. Some patients may continue taking a small maintenance dose, while others can stop the treatment altogether once the condition stabilizes. However, suppressing the immune system increases the risk of infections and can cause other side effects such as thinning of the bones (osteoporosis), weight gain, mood changes, elevated blood sugar levels, and cosmetic problems like facial swelling and acne.^[8]

Because of these side effects, doctors carefully monitor patients taking immunosuppressants. They may also prescribe additional medications to prevent complications such as infections or osteoporosis. For example, patients might receive calcium supplements and vitamin D to protect bone health, or antiviral medications if the glomerulonephritis is linked to a viral infection.^[21]

Managing High Cholesterol

High cholesterol levels are common in people with chronic glomerulonephritis, particularly in those with significant protein loss in the urine. Elevated cholesterol increases the risk of heart and vascular disease, which are already more common in people with kidney disease. Doctors often recommend statins, medications that lower cholesterol levels and help protect against cardiovascular complications.^[8]

Dietary Modifications

What you eat plays an important role in managing chronic glomerulonephritis. In mild cases, a doctor or dietitian will provide advice about dietary changes. Patients are typically advised to reduce the amount of salt, fat, protein, and potassium in their diet, and to drink less fluid. These adjustments help control blood pressure and ensure the amount of fluid in the body is properly regulated.^[8]

Dietary protein restriction, phosphate restriction, and hyperlipidemia control may have significant impact on slowing disease progression. In obese patients, weight reduction and in some cases bariatric surgery may have beneficial effects on chronic kidney disease. Patients should have regular reviews to check blood pressure, the levels of salt and potassium in the urine, and how well the kidneys are working.^[9]

Treating Complications of Kidney Disease

As chronic glomerulonephritis progresses and the GFR decreases, various complications emerge. When the GFR falls below 60-70 mL/min, waste products begin to accumulate in the blood, causing azotemia (elevated levels of blood urea nitrogen and creatinine). Further decline in kidney function leads to additional problems including anemia, bone disease, electrolyte imbalances, and fluid overload.^[2]

Anemia develops because damaged kidneys produce less erythropoietin, a hormone that stimulates red blood cell production. Treatment may involve medications that replace erythropoietin or supplements to address iron deficiency. Kidney disease also affects vitamin D production, leading to low calcium levels, high phosphorus levels, and bone problems collectively known as renal osteodystrophy. Managing these complications requires additional medications and careful monitoring.^[2]

Duration of Treatment

Treatment for chronic glomerulonephritis is typically long-term and often lifelong. The specific duration depends on the underlying cause, the severity of kidney damage, and how well the disease responds to treatment. Some patients may need to take blood pressure medications and other kidney-protective drugs indefinitely to slow progression. Regular follow-up appointments are essential to monitor kidney function, adjust medications, and detect any changes early.^[9]

Advanced Treatment Options

In some severe cases, when inflammation is particularly aggressive, doctors may use plasma exchange (also called plasmapheresis). During this procedure, a patient is connected to a machine that removes some of their blood. The plasma, which contains proteins that can cause kidney inflammation, is separated from the blood cells and removed. A plasma substitute is then added before the blood is returned to the body. This treatment is used in certain circumstances when the condition is severe and other treatments are not sufficient.^[8]

If chronic glomerulonephritis progresses despite treatment and kidneys can no longer adequately filter blood, patients may require kidney replacement therapy. This includes dialysis, a treatment that takes over part of the kidney’s job by removing waste products from the body, or a kidney transplant, where a healthy kidney from a donor is surgically implanted to replace the damaged kidney.^[8]

Treatment Approaches in Clinical Trials

While standard treatments help many patients, researchers continue to explore new therapies through clinical trials. These studies test innovative medications and treatment strategies that may offer better outcomes or fewer side effects than current options. Clinical trials move through different phases, each designed to answer specific questions about safety and effectiveness.^[12]

Understanding Clinical Trial Phases

Phase I trials focus primarily on safety. Researchers test new treatments in small groups to determine safe doses and identify side effects. Phase II trials expand to larger groups and assess whether the treatment is effective while continuing to monitor safety. Phase III trials compare the new treatment with standard therapies in large populations to determine if it offers advantages. Phase IV trials occur after a treatment is approved and monitor long-term effects and optimal use in real-world settings.^[12]

Emerging Therapies for Glomerulonephritis

Several promising new approaches are being investigated for treating chronic glomerulonephritis. Novel targeted immunotherapies utilizing engineered delivery platforms and biologicals like monoclonal antibodies are progressing in research pipelines. These treatments aim to more precisely target the immune processes causing kidney damage while potentially offering safer, more effective alternatives to current standard immunosuppression.^[24]

Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors), originally developed for diabetes, are being studied as adjunctive treatment for proteinuria in glomerulonephritis. These medications may help reduce protein loss in the urine and slow kidney disease progression through mechanisms beyond glucose control. Some studies suggest they may be beneficial even in patients without diabetes.^[9]

A newer class of medication called nonsteroidal mineralocorticoid receptor antagonists, with finerenone as an example, is being investigated for chronic glomerulonephritis caused by diabetes mellitus. These drugs work differently from traditional medications and may offer additional kidney protection with fewer side effects related to electrolyte imbalances.^[9]

Advanced Diagnostic and Monitoring Tools

Research is also advancing in how glomerulonephritis is diagnosed and monitored. High-throughput biomarker assays can detect specific proteins or molecules in blood or urine that indicate kidney damage earlier than traditional tests. Artificial intelligence and machine learning algorithms are being developed to analyze complex patterns in medical data, potentially improving early detection of kidney damage and helping doctors create personalized treatment plans for individual patients.^[24]

These technological advances may help identify which patients are at highest risk for progression and which treatments are most likely to work for specific individuals. This approach, called precision medicine, aims to move beyond one-size-fits-all treatment strategies.^[24]

Exploring New Therapeutic Targets

Researchers are investigating several innovative therapeutic approaches. Studies are examining how modulating microbiome-immune interactions might influence kidney inflammation. The community of microorganisms living in the gut can affect immune function, and altering this community through diet, probiotics, or other interventions might offer new treatment possibilities.^[24]

Nanotechnology is another frontier, with researchers developing tiny particles that can deliver drugs directly to inflamed kidney tissue while minimizing effects on the rest of the body. Stem cell therapy is being explored as a potential way to regenerate damaged kidney tissue, though this remains in early research stages.^[24]

Participating in Clinical Trials

Clinical trials offer patients access to cutting-edge treatments before they become widely available. However, participation involves careful consideration. Trials have specific eligibility criteria based on factors like disease stage, previous treatments, and overall health. Some trials may be available only in certain locations, such as specialized research centers in Europe, the United States, or other regions.^[12]

Before joining a trial, patients receive detailed information about the study’s purpose, procedures, potential benefits, and risks. Participation is always voluntary, and patients can withdraw at any time. While trials may offer hope for better treatments, they also involve uncertainty, as new therapies have not been fully proven effective and may have unknown side effects.^[12]

Lifestyle and Supportive Measures

Beyond medications and medical procedures, lifestyle modifications play a crucial role in managing chronic glomerulonephritis. Staying physically active helps maintain overall health and blood pressure control. Regular exercise, within limits set by your doctor, can improve cardiovascular health and help manage weight, both important for kidney protection.^[18]

Managing other health conditions is equally important. Patients with diabetes must carefully control their blood sugar levels, as high glucose can accelerate kidney damage. Those with heart disease need appropriate cardiac care, as cardiovascular problems and kidney disease often occur together and worsen each other.^[9]

Because chronic glomerulonephritis can make patients more vulnerable to infections, protecting against illness is important. Doctors recommend seasonal flu vaccines and pneumonia vaccines (pneumococcal vaccines) to reduce infection risk. These preventive measures are particularly important for patients taking immunosuppressant medications.^[21]

Seeking support from family, friends, and counsellors can help patients cope with the emotional challenges of living with a long-term illness. Chronic conditions can be difficult and stressful, affecting mental health and quality of life. Many patients benefit from connecting with support groups where they can share experiences with others facing similar challenges.^[22]

Monitoring and Follow-up Care

Regular, and sometimes frequent, monitoring of kidney function is critical for patients with chronic glomerulonephritis. Follow-up care is a key part of treatment and safety. Patients should attend all scheduled appointments and contact their healthcare provider if problems arise. Monitoring typically includes blood tests to check creatinine levels and GFR, urine tests to measure protein and blood, and blood pressure measurements.^[9]

Doctors also watch for signs of complications and adjust treatments accordingly. Patients should know their test results and keep a list of medications they take. Understanding personal health numbers empowers patients to participate actively in their care and recognize when changes occur.^[22]

Most common treatment methods

• Blood pressure management
  • ACE inhibitors such as enalapril, captopril, lisinopril, benazepril, and fosinopril to lower blood pressure and reduce protein loss in urine
  • Angiotensin receptor blockers (ARBs) as alternatives to ACE inhibitors
  • Multiple antihypertensive medications often needed to adequately control blood pressure
  • Lifestyle modifications including reduced salt intake
• Fluid management
  • Loop diuretics to increase urine production and reduce swelling
  • Thiazide diuretics for blood pressure control
  • Restricted dietary sodium intake to control fluid accumulation
  • Fluid restriction in advanced cases
• Immunosuppressive therapy
  • Corticosteroids such as prednisolone to reduce inflammation and suppress immune system
  • Dose gradually reduced as kidneys recover
  • Additional medications to prevent side effects like infections and osteoporosis
  • Calcium supplements and vitamin D for bone protection
• Cholesterol management
  • Statins to reduce cholesterol and protect against cardiovascular complications
  • Lifestyle modifications including dietary fat reduction
• Dietary modifications
  • Reduced salt, fat, protein, and potassium intake
  • Dietary protein restriction to slow disease progression
  • Phosphate restriction
  • Weight reduction for obese patients
• Treatment of complications
  • Erythropoietin-stimulating agents or iron supplements for anemia
  • Medications to manage calcium, phosphorus, and vitamin D imbalances
  • Treatment for bone disease (renal osteodystrophy)
• Advanced interventions
  • Plasma exchange for severe cases with aggressive inflammation
  • Kidney dialysis when kidneys can no longer adequately filter blood
  • Kidney transplantation for end-stage kidney disease
• Emerging therapies in clinical trials
  • SGLT2 inhibitors to reduce protein loss and slow progression
  • Nonsteroidal mineralocorticoid receptor antagonists like finerenone
  • Targeted immunotherapies and monoclonal antibodies
  • High-throughput biomarker assays for early detection
  • Artificial intelligence and machine learning for personalized treatment